Successful commercialisation of a regulated pharmaceutical product is directly related to full compliance with cGMP rules, requiring a high level of analytical, validation and regulatory support. CordenPharma stands above the competition with trained professionals who adhere to the highest possible regulatory standards at all stages of product development.

Analytical Support for Our Contracted Customers

Throughout the whole development and industrial lifecycle of all of our APIs we provide analytical support for contracted customers as required to be cGMP compliant.

All API batches are released by independent Quality Control departments. Analytical methods are developed and validated in accordance with ICH guidelines, not only applying to release test methods, but also to In-Process Controls and test methods used in cleaning validation.  Stability studies are conducted including forced degradation studies as well as investigational and formal ICH stability studies.

For all APIs the structures are proven through instrumental analyses including NMR, LC-MS, GC-MS and X-ray structural analysis. The respective analytical reference standards are prepared and analytically characterized. As required by ICH guidelines, API impurities like side products or degradants are identified through instrumental analysis and reference samples thereof are synthesized.

Validation Support for Our Contracted Customers

At all CordenPharma sites validations of all cGMP relevant systems are conducted as required to be cGMP compliant, from risk analysis and execution right through to evaluation and validation reporting of:
  • Manufacturing Processes
  • Cleaning
  • Analytical Methods
  • IT-systems

All relevant production / analytical equipment is qualified according to cGMP requirements

Regulatory Support for Our Contracted Customers

CordenPharma is linking together a legacy of expertise to navigate the complex regulations and registration processes necessary to test new drug products and bring them to market. Experienced, on-site Regulatory Affairs teams ensure regulatory compliance by preparing and maintaining regulatory documentation such as:
  • Drug Master Files (DMFs in USA, Europe, Japan, Canada, etc)
  • CMC quality module documentation in CTD format suitable for the submission of IND, IMPD, NDA, and MAA dossiers
  • EP-Certificates of suitability (CEP)

As required we support approvals of our contracted customers' NDAs and MAAs during registration as well as post-approvals through response to questions issued by the authorities.